Sectors

STAA
STAAR Surgical Company
25.25
1 x 25.10
6 x 25.37
bid
ask
+
0.13
0.50%
09:36 AM
timesize
Ytd9.33%
1y-7.39%
25.25
day range
25.75
15.59
52 week range
35.87
Open25.50Prev Close25.12Low25.25High25.75Mkt Cap1.26B
Vol15.60KAvg Vol915.30KEPS0.57P/E44.44Forward P/E24.49
Beta1.26Short Ratio7.63Inst. Own113.35%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg27.16200-d Avg24.281yr Est28.89
Earning
DateForEstimateReportedSurprisesurprise %
2026-08-122026-070.21N/AN/AN/A
2026-05-132026-040.050.380.33600.85%
2026-03-032026-010.18-0.2-0.38-211.11%
2025-11-052025-090.180.460.28155.56%
2025-08-062025-06-0.56-0.070.4987.50%
2025-05-072025-03-0.59-0.520.0711.86%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-04WedbushUpgradeOutperformOutperform
2026-07-28UBSUpgradeSell
2026-07-22WedbushUpgradeOutperformOutperform
2026-07-16WedbushUpgradeOutperformOutperform
2026-05-29WedbushUpgradeOutperformOutperform
2026-05-15Wells FargoUpgradeEqual-WeightEqual-Weight
Profile
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Insider Holder
DateNameRelationQuantityDescription
2026-07-30ANDREWS DEBORAH JChief Financial Officer36.34KConversion of Exercise of derivative security
2026-03-12BROADWOOD PARTNERS, L.P.Beneficial Owner of more than 10% of a Class of Security0.00Purchase
2026-06-17BUTCHER ARTHUR CDirector9.55KConversion of Exercise of derivative security
2025-03-04FARRELL STEPHEN CChief Executive Officer35.16KConversion of Exercise of derivative security
2026-07-30FOUST WARRENChief Executive Officer86.56KConversion of Exercise of derivative security
2026-06-17JIANG WEIDirector77.13KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Broadwood Capital, Inc.16.12M390.36M32.38%
2026-06-29Blackrock Inc.6.73M162.96M13.52%
2026-06-29Yunqi Capital Ltd3.26M78.86M6.54%
2026-03-30Madison Avenue Partners, LP2.44M59.11M4.90%
2026-03-30Vanguard Portfolio Management LLC2.12M51.41M4.27%
2026-06-29State Street Corporation1.77M42.84M3.55%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29iShares Trust-iShares Core S&P Small-Cap ETF3.00M72.65M6.03%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.10M26.53M2.20%
2026-06-29iShares Trust-iShares Russell 2000 ETF888.86K21.52M1.79%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund799.83K19.36M1.61%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund556.76K13.48M1.12%
2026-06-29SPDR SERIES TRUST-State Street SPDR Portfolio S&P 600 Small Cap ETF457.47K11.08M0.92%
Split
SplitDate
1 : 21992-05-18